Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin in Real-life Evaluation study for LUTS due to benign prostatic hyperplasia
2011-000045-20Phase 4Completed
- Sponsor
- Recordati SpA
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of silodosin in benign prostatic hyperplasia (BPH), sponsored by Recordati SpA. Primary endpoints: Percentage of treatment responders at study end and International Prostate Symptom Score total score. Started Mar 2011; status: completed.
02
Drugs
silodosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2011-000045-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000045-20.